Our CEO, Dr. Tuvik Beker, will be presenting a Showcase at PMWC 2025 discussing the exciting progress Pangea Biomed has been making in unlocking the promise and hope of precision oncology for patients that need it most. He will discuss how ENLIGHT is empowering oncologists to make more informed treatment decisions, leading to better patient outcomes, and how ENLIGHT is accelerating the development of targeted cancer therapies, bringing new hope to patients faster. He will also be talking about what lies ahead: recent validations of ENLIGHT-DP (our next-generation predictive biomarker based on histopathology slide images), our regulatory roadmap, and our recent commercial launch.